Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

COVID-19 infections decrease total cholesterol, LDL-C, HDL-C, and apolipoprotein AI, A-II,
and B levels while triglyceride levels may be increased or inappropriately normal for the …

Numerous studies have observed a decrease in total cholesterol, LDL-C, HDL-C, and
apolipoprotein B and AI levels in patients with COVID-19 infections, similar to what is …

The impact of statins on COVID-19 remains unclear. This study aims to investigate whether
statin exposure assessed both in the population and in well-defined cohorts of COVID-19 …

Purpose The COVID‐19 pandemic had an impact on health care, with disruption to routine
clinical care. Our aim was to describe changes in prescription drugs dispensing in the …

There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …

Mandatory working from home is one of the consequences of the COVID-19 pandemic for a
large number of workers. Transition to working from home may significantly impact lifestyle …

Paxlovid™ is a promising antiviral oral medication for patients at a high risk of a severe form
of COVID-19. Regarding COVID-19 patients who have hypercholesterolemia and are at high …

Myopathy is the most common side effect of statins, but it has not been addressed effectively.
In anticipation of its wider use as a small molecule to complement the current COVID-19 …

Background: Recent epidemiological studies remain controversial regarding the association
between statin use and reducing the risk of mortality among individuals with COVID-19 …